ahlam1399
09-01-2015, 05:51 PM
Europe gets Amgen cholesterol drug for 50-60 pct of U.S. price
LONDON, Sept 1 (Reuters) - Amgen is launching its injectable cholesterol drug in Europe at around half the U.S. price, in a move likely to stoke controversy about the way Americans end up paying far more than others for new medicines.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/49798b6a/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=BxbEKTk0sNU:wY82bsMC-b8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=BxbEKTk0sNU:wY82bsMC-b8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=BxbEKTk0sNU:wY82bsMC-b8:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=BxbEKTk0sNU:wY82bsMC-b8:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=BxbEKTk0sNU:wY82bsMC-b8:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/BxbEKTk0sNU
LONDON, Sept 1 (Reuters) - Amgen is launching its injectable cholesterol drug in Europe at around half the U.S. price, in a move likely to stoke controversy about the way Americans end up paying far more than others for new medicines.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/49798b6a/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=BxbEKTk0sNU:wY82bsMC-b8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=BxbEKTk0sNU:wY82bsMC-b8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=BxbEKTk0sNU:wY82bsMC-b8:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=BxbEKTk0sNU:wY82bsMC-b8:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=BxbEKTk0sNU:wY82bsMC-b8:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/BxbEKTk0sNU